In this article, Dr Frank Binder, VP of global supply chain management at Santen and keynote speaker at NEXUS '17 in Barcelona, discusses the challenges and opportunities that serialisation presents to mid-sized companies.
Implementing a fully compliant serialisation solution in time for upcoming US and European regulations in 2017 and 2019 respectively is a complex task for any pharmaceutical company. While larger companies have the budget and expertise to dedicate full time resources to the process, mid-sized companies are faced with a more challenging scenario, with many falling behind in their serialisation preparations.